RecruitingPhase 3NCT03150693
Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia
Sponsor: Alliance for Clinical Trials in Oncology
Aurora, CO · Boulder, CO · +452 more sites
Clinical trials in Lafayette, CO
7 recruiting studies have a site in or near Lafayette, CO, Colorado.
Top conditions here
All conditions
- Alzheimer's Disease
- Asthma
- Breast Cancer
- COPD
- Crohn's Disease
- Depression
- Type 1 Diabetes
- Type 2 Diabetes
- Heart Failure
- Hypertension
- Leukemia
- Lung Cancer
- Lupus
- Migraine
- Multiple Sclerosis
- Obesity
- Parkinson's Disease
- Prostate Cancer
- Psoriasis
- Rheumatoid Arthritis
- Schizophrenia
- Sickle Cell Disease
- Ulcerative Colitis
- Colorectal Cancer
Showing 7 of 7 studies
RecruitingPhase 3NCT04267848
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Sponsor: National Cancer Institute (NCI)
Aurora, CO · +1147 more sites
RecruitingPhase 3NCT06498635
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
Sponsor: National Cancer Institute (NCI)
Denver, CO · Grand Junction, CO · Lafayette, CO · +278 more sites
RecruitingNot applicableNCT06995898
The Vanguard Study: Testing a New Way to Screen for Cancer
Sponsor: National Cancer Institute (NCI)
Cheyenne Wells, CO · Denver, CO · Fort Collins, CO · +42 more sites
RecruitingPhase 3NCT05812807
Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab
Sponsor: Alliance for Clinical Trials in Oncology
Aurora, CO · Colorado Springs, CO · +825 more sites
RecruitingPhase 2 / Phase 3NCT03851445
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Sponsor: SWOG Cancer Research Network
Aurora, CO · +1226 more sites
RecruitingPhase 3NCT05929768
Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast Cancer
Sponsor: SWOG Cancer Research Network
Aurora, CO · Boulder, CO · +952 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.